-
Merck, Pfizer keep high-flying vaccine sales intact with key CDC backing
fiercepharma
July 04, 2019
Looking ahead, the two companies could end up in a new head-to-head contest with their next-generation pneumococcal vaccines with billions of dollars at stake. Pfizer is developing its 20-valent follow-up to Prevnar 13, while Merck has a 15-valent vaccine
-
Cue the ‘revolving door’ criticism: Former FDA commissioner Gottlieb joins Pfizer’s board
fiercepharma
July 04, 2019
When former FDA commissioner Scott Gottlieb, M.D., resigned back in March, he said he wanted to spend more time with his family.
-
Array played with Pfizer’s eagerness to land a deal on time—and got itself a better offer
fiercepharma
July 04, 2019
When it comes to buying an experienced cancer drug specialist, a bidding war is naturally expected.
-
Warren blasts Gottlieb's jump to Pfizer, but ex-FDA chief says he's 'proud'
fiercepharma
July 04, 2019
Scott Gottlieb and Pfizer surely knew critics would challenge the former FDA commissioner’s decision to join the pharma giant's board—less than three months after his departure from the agency, no less.
-
Pfizer Completes Acquisition of Therachon
americanpharmaceuticalreview
July 03, 2019
Pfizer announced the successful completion of its acquisition of the privately held clinical-stage biotechnology company Therachon Holding AG.
-
Pfizer acquires rare disease biotech Therachon for $340m
pharmaceutical-technology
July 03, 2019
Pfizer has announced it has completed its acquisition of US-based Therachon, a clinical stage biotechnology company focusing on rare diseases; the acquisition was first initiated in early May 2019.
-
FDA Approves Zirabev (bevacizumab-bvzr), a Biosimilar to Avastin
drugs
July 01, 2019
FDA Approves Zirabev.
-
Pharmaceutical company combats counterfeit Viagra
europeanpharmaceuticalreview
July 01, 2019
Pharmaceutical company Pfizer was able to target the distribution of counterfeit Viagra in Hong Kong, S.A.R., China through serialisation technology.
-
Former Pfizer site in Puerto Rico picked up by medical marijuana producer
fiercepharma
June 28, 2019
Looks like unloading surplus manufacturing sites to the cannabis industry is turning into a budding business for pharma.
-
GSK reported to have started the sale of $1.2 billion consumer health drugs
europeanpharmaceuticalreview
June 27, 2019
According to Reuters, GSK has started the sale of some consumer health brands as it seeks to raise £1 billion.